Albert A. Holman Iii.
Director, BridgeBio Oncology Therapeutics, Inc.
Companies
- BridgeBio Oncology Therapeutics, Inc.Board member Feb 11, 2025 to Feb 11, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- BridgeBio Oncology Therapeutics, Inc. BBOT30,000 shares2$84.2K at $2.81Aug 11, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 11, 2025Exercised options 30,000 shares of BridgeBio Oncology Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2